Brind.
  1. Aurora Cannabis Inc., a company based in Canada, operates globally including Europe with GMP-certified facilities in Germany, and its shares trade on the NASDAQ. Miguel Martin is the Executive Chairman and CEO.
  2. Aurora Cannabis has successfully navigated regulatory challenges and achieved strong performance in key European markets, including developments related to Poland.

Aurora Cannabis's Brampton facility received EU-GMP certification, positioning the company in the international medical cannabis market.

1 report, 1 independent Updated Jul 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Aurora Cannabis's Brampton facility received EU-GMP certification, positioning the company in the international medical cannabis market.

Who's involved

What this event is mainly about
CanniMedEurope

Keep exploring

Part of

Aurora Cannabis has successfully navigated regulatory challenges and achieved strong performance in key European markets, including developments related to Poland.

Also in this story

All 4 developments

Within Aurora Cannabis Inc., a company based in Canada, operates globally including Europe with GMP-certified facilities in Germany, and its shares trade on the NASDAQ. Miguel Martin is the Executive Chairman and CEO.

The entities involved

Coverage

Newest first; wire copies grouped
  • Market ExclusiveWeekly Roundup on the Cannabis Sector & Psychedelic Sector Key Takeaways; Cannabis Sector Aurora Cannabis received EU-GMP certification for its Brampton distribution facility High Tide secured $30 mi